197 related articles for article (PubMed ID: 11114638)
1. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
[TBL] [Abstract][Full Text] [Related]
2. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
3. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
Blansfield JA; Choyke L; Morita SY; Choyke PL; Pingpank JF; Alexander HR; Seidel G; Shutack Y; Yuldasheva N; Eugeni M; Bartlett DL; Glenn GM; Middelton L; Linehan WM; Libutti SK
Surgery; 2007 Dec; 142(6):814-8; discussion 818.e1-2. PubMed ID: 18063061
[TBL] [Abstract][Full Text] [Related]
4. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
[TBL] [Abstract][Full Text] [Related]
5. The hereditary forms of pancreatic neuroendocrine tumors.
DeLellis RA
Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
[TBL] [Abstract][Full Text] [Related]
6. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP
World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474
[TBL] [Abstract][Full Text] [Related]
9. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
[TBL] [Abstract][Full Text] [Related]
11. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
12. Somatic mosaicism in von Hippel-Lindau Disease.
Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
[TBL] [Abstract][Full Text] [Related]
13. Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease.
Tirosh A; Sadowski SM; Linehan WM; Libutti SK; Patel D; Nilubol N; Kebebew E
JAMA Oncol; 2018 Jan; 4(1):124-126. PubMed ID: 29075773
[TBL] [Abstract][Full Text] [Related]
14. Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors.
Weisbrod AB; Zhang L; Jain M; Barak S; Quezado MM; Kebebew E
Horm Cancer; 2013 Jun; 4(3):165-75. PubMed ID: 23361940
[TBL] [Abstract][Full Text] [Related]
15. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
16. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
17. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.
Corcos O; Couvelard A; Giraud S; Vullierme MP; Dermot O'Toole ; Rebours V; Stievenart JL; Penfornis A; Niccoli-Sire P; Baudin E; Sauvanet A; Levy P; Ruszniewski P; Richard S; Hammel P
Pancreas; 2008 Jul; 37(1):85-93. PubMed ID: 18580449
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
19. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
20. [Von Hippel-Lindau disease].
Shuin T; Ashida S; Yao M; Kanno H
Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
